5-132213966-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PP3_ModeratePP5BS2
The NM_001017974.2(P4HA2):āc.419A>Gā(p.Gln140Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: š 0.000026 ( 0 hom., cov: 32)
Exomes š: 0.0000096 ( 0 hom. )
Consequence
P4HA2
NM_001017974.2 missense
NM_001017974.2 missense
Scores
10
8
1
Clinical Significance
Conservation
PhyloP100: 6.24
Genes affected
P4HA2 (HGNC:8547): (prolyl 4-hydroxylase subunit alpha 2) This gene encodes a component of prolyl 4-hydroxylase, a key enzyme in collagen synthesis composed of two identical alpha subunits and two beta subunits. The encoded protein is one of several different types of alpha subunits and provides the major part of the catalytic site of the active enzyme. In collagen and related proteins, prolyl 4-hydroxylase catalyzes the formation of 4-hydroxyproline that is essential to the proper three-dimensional folding of newly synthesized procollagen chains. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.917
PP5
Variant 5-132213966-T-C is Pathogenic according to our data. Variant chr5-132213966-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 372166.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAdExome4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P4HA2 | NM_001365677.2 | c.419A>G | p.Gln140Arg | missense_variant | 5/15 | ENST00000379104.7 | NP_001352606.1 | |
P4HA2 | NM_001017974.2 | c.419A>G | p.Gln140Arg | missense_variant | 5/15 | ENST00000360568.8 | NP_001017974.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P4HA2 | ENST00000379104.7 | c.419A>G | p.Gln140Arg | missense_variant | 5/15 | 1 | NM_001365677.2 | ENSP00000368398.2 | ||
P4HA2 | ENST00000360568.8 | c.419A>G | p.Gln140Arg | missense_variant | 5/15 | 1 | NM_001017974.2 | ENSP00000353772.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152254
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251448Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135890
GnomAD3 exomes
AF:
AC:
15
AN:
251448
Hom.:
AF XY:
AC XY:
10
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727214
GnomAD4 exome
AF:
AC:
14
AN:
1461816
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74378
GnomAD4 genome
AF:
AC:
4
AN:
152254
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
8
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Myopia 25, autosomal dominant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 05, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D;.;.;D;D;.;D;.;.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;.;.;.;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;H;H;H;H;H;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;.;D;D;.;.;.
Polyphen
D;D;D;D;D;D;.;.;.;.;.;.
Vest4
MutPred
Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);.;Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);Gain of methylation at Q140 (P = 0.0517);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at